Abstract
BackgroundA craniotomy is required to access the brain for tumor resection or epilepsy treatment, and despite precautionary measures, infectious complications occur at a frequency of 1–3%. Approximately half of craniotomy infections are caused by Staphylococcus aureus (S. aureus) that forms a biofilm on the bone flap, which is recalcitrant to antibiotics. Our prior work in a mouse model of S. aureus craniotomy infection revealed a critical role for myeloid differentiation factor 88 (MyD88) in bacterial containment and pro-inflammatory mediator production. Since numerous receptors utilize MyD88 as a signaling adaptor, the current study examined the importance of Toll-like receptor 2 (TLR2) and TLR9 based on their ability sense S. aureus ligands, namely lipoproteins and CpG DNA motifs, respectively. We also examined the role of caspase-1 based on its known association with TLR signaling to promote IL-1β release.MethodsA mouse model of craniotomy-associated biofilm infection was used to investigate the role of TLR2, TLR9, and caspase-1 in disease progression. Wild type (WT), TLR2 knockout (KO), TLR9 KO, and caspase-1 KO mice were examined at various intervals post-infection to quantify bacterial burden, leukocyte recruitment, and inflammatory mediator production in the galea, brain, and bone flap. In addition, the role of TLR2-dependent signaling during microglial/macrophage crosstalk with myeloid-derived suppressor cells (MDSCs) was examined.ResultsTLR2, but not TLR9, was important for preventing S. aureus outgrowth during craniotomy infection, as revealed by the elevated bacterial burden in the brain, galea, and bone flap of TLR2 KO mice concomitant with global reductions in pro-inflammatory mediator production compared to WT animals. Co-culture of MDSCs with microglia or macrophages, to model interactions in the brain vs. galea, respectively, also revealed a critical role for TLR2 in triggering pro-inflammatory mediator production. Similar to TLR2, caspase-1 KO animals also displayed increased S. aureus titers coincident with reduced pro-inflammatory mediator release, suggestive of pathway cooperativity. Treatment of caspase-1 KO mice with IL-1β microparticles significantly reduced S. aureus burden in the brain and galea compared to empty microparticles, confirming the critical role of IL-1β in limiting S. aureus outgrowth during craniotomy infection.ConclusionsThese results demonstrate the existence of an initial anti-bacterial response that depends on both TLR2 and caspase-1 in controlling S. aureus growth; however, neither pathway is effective at clearing infection in the WT setting, since craniotomy infection persists when both molecules are present.
Highlights
A craniotomy is required to access the brain during neurosurgical procedures, such as tumor resection or epilepsy treatment, where the piece of resected skull, or bone flap, is replaced intraoperatively
Aldrich et al Journal of Neuroinflammation (2020) 17:114 (Continued from previous page). These results demonstrate the existence of an initial anti-bacterial response that depends on both Tolllike receptor 2 (TLR2) and caspase-1 in controlling S. aureus growth; neither pathway is effective at clearing infection in the Wild type (WT) setting, since craniotomy infection persists when both molecules are present
Our recent reports established the biofilm properties associated with the mouse model of S. aureus craniotomy infection, including biofilms that were ultrastructurally indistinguishable from an infected bone flap of a patient with confirmed S. aureus infection as demonstrated by scanning electron microscopy (SEM) [9] and the failure to clear infection in the mouse craniotomy model following treatment with systemic antibiotics, which is the functional definition of a biofilm based on its antibiotic tolerance [21]
Summary
A craniotomy is required to access the brain during neurosurgical procedures, such as tumor resection or epilepsy treatment, where the piece of resected skull, or bone flap, is replaced intraoperatively. Numerous approaches are employed to prevent infectious complications following craniotomy, infections occur in 1– 3% of patients [1]. A second treatment strategy is to discard the infected bone flap, and after a variable treatment period of i.v. and oral antibiotics spanning from weeks to months, a cranioplasty is performed to seal the cranium with either an alloplastic implant or bone graft [8]. In both scenarios, infections can recur, which underscores the need to understand how bacterial biofilms subvert immune-mediated clearance to establish persistent infection. We examined the role of caspase-1 based on its known association with TLR signaling to promote IL-1β release
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.